The Natus Cranial Access Kit is designed to be a complete, single use and disposable accessory an...
FDA Device Recall #Z-0735-2023 — Class II — November 18, 2022
Recall Summary
| Recall Number | Z-0735-2023 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 18, 2022 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Natus Medical Incorporated |
| Location | San Diego, CA |
| Product Type | Devices |
| Quantity | 249 kits |
Product Description
The Natus Cranial Access Kit is designed to be a complete, single use and disposable accessory and instrumentation set that is used to create an intracranial burr-hole typically required for procedures such as ventriculostomy or intracranial pressure (ICP) monitoring. The various components of the kit are comprised to make it convenient for the practitioner to have all that they need in one place for fast and efficient intracranial access. cerebral spinal fluid (CSF).
Reason for Recall
Due to Cranial Access Kits containing recalled sterile surgical drapes. The sterile surgical drapes are being recalled due to the liner on the adhesive component is difficult to remove without damaging the product and may render the product unusable.
Distribution Pattern
U.S. Nationwide distribution in the states of AK, CA, CT, DC, FL, GA, IA, ID, IL, KS , MD, MI, MT, ND, NE, NJ, NV, NY, OH, OR, TX, and WA.
Lot / Code Information
Part Number: HITH1 UDI-DI Code: 382830048590 Lot Number: 22GDB675 Part Number: HITHNDRZR UDI-DI Code: 382830048620 Lot Number: 22HDA557 Part Number: HITHLT UDI-DI Code: 382830048637 Lot Number: 22IDB724
Other Recalls from Natus Medical Incorporated
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0635-2024 | Class II | EDS 3 CSF External Drainage System, REF: NT821... | Nov 28, 2023 |
| Z-0634-2024 | Class II | External Drainage System Collection Bag, REF: ... | Nov 28, 2023 |
| Z-2701-2017 | Class II | The Olympic Pasteurmatic 3000 and Olympic Paste... | May 22, 2017 |
| Z-1924-2017 | Class II | Second generation neoBLUE LED Phototherapy Ligh... | Apr 3, 2017 |
| Z-0770-2017 | Class II | Natus neoBLUE blanket LED Phototherapy system, ... | Oct 28, 2016 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.